Shrom, D.S.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Detection and prediction of periodic patterns by the retina

Schwartz, Greg, Harris, Rob, Shrom, David, Berry, Michael J

Journal:

Nature Neuroscience

Year:

2007

Language:

english

File:

PDF, 193 KB

english, 2007

2

Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3)

Menter, A., Warren, R.B., Langley, R.G., Merola, J.F., Kerr, L.N., Dennehy, E.B., Shrom, D., Amato, D., Okubo, Y., Reich, K.

Journal:

Journal of the European Academy of Dermatology and Venereology

Year:

2017

Language:

english

File:

PDF, 250 KB

english, 2017

3

Greater Cumulative Benefits from Ixekizumab versus Ustekinumab Treatment over 52 Weeks for Patients with Moderate-to-Severe Psoriasis in a Randomized, Double-Blinded Phase 3b Clinical Trial

Blauvelt, Andrew, Lomaga, Mark, Burge, Russel, Zhu, Baojin, Shen, Wei, Shrom, David, Dossenbach, Martin, Pinter, Andreas

Journal:

Journal of Dermatological Treatment

Year:

2019

Language:

english

File:

PDF, 977 KB

english, 2019

4

Formalin treatment for intractable hemorrhagic cystitis. A review of the literature with 16 additional cases

Stanley H. Shrom, Milton H. Donaldson, John W. Duckett Jr., Alan J. Wein

Journal:

Year:

1976

Language:

english

File:

PDF, 453 KB

english, 1976

5

Scintillation detectors working with CaF2- Eu single crystals

B. V. Shul'gin, S. I. Buzmakova, L. V. Viktorov, A. L. Krymov, V. L. Petrov, S. V. Podurovskii, A. A. Kozlov, B. M. Shapiro, M. Yu. Shrom, A. I. Nepomnyashchikh, P. V. Figura, V. M. Lakhov

Journal:

Year:

1993

Language:

english

File:

PDF, 525 KB

english, 1993

6

CaF2-Eu single-crystal scintillation blocks for detectingβ-radiation

A. A. Kozlov, B. M. Shapiro, M. Y. Shrom, S. V. Bryzgalov, N. D. Betenekov, L. V. Viktorov, E. I. Denisov, A. Y. Kuznetsov, B. V. Shul'gin

Journal:

Year:

1994

Language:

english

File:

PDF, 353 KB

english, 1994

7

The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes

S. Sarwat, L. L. Ilag, M. A. Carey, D. S. Shrom, R. J. Heine

Journal:

Diabetic Medicine

Year:

2010

Language:

english

File:

PDF, 134 KB

english, 2010

8

Does A1c consistently reflect mean plasma glucose?

David SHROM, Samiha SARWAT, Liza ILAG, Zachary T. BLOOMGARDEN

Journal:

Journal of Diabetes

Year:

2010

Language:

english

File:

PDF, 198 KB

english, 2010

9

The protective effect of heparin in experimental bladder infection

Philip M. Hanno, C.Lowell Parsons, Stanley H. Shrom, Robert Fritz, S.Grant Mulholland

Journal:

Journal of Surgical Research

Year:

1978

Language:

english

File:

PDF, 2.58 MB

english, 1978

10

Deficient Neurogenesis in Forebrain-Specific Presenilin-1 Knockout Mice Is Associated with Reduced Clearance of Hippocampal Memory Traces

Ruiben Feng, Claire Rampon, Ya-Ping Tang, David Shrom, Janice Jin, Maureen Kyin, Bryce Sopher, George M Martin, Seong-Hun Kim, Ronald B Langdon, Sangram S Sisodia, Joe Z Tsien

Journal:

Year:

2001

Language:

english

File:

PDF, 593 KB

english, 2001

11

Erratum

Ruiben Feng, Claire Rampon, Ya-Ping Tang, David Shrom, Janice Jin, Maureen Kyin, Bryce Sopher, Miles W. Miller, Carol B. Ware, George M. Martin, Seong H. Kim, Ronald B. Langdon, Sangram S. Sisodia, Jo

Journal:

Year:

2002

Language:

english

File:

PDF, 17 KB

english, 2002

12

P195 Rapport entre les mesures de glycémie et l’HbA1c chez des patients diabétiques de type 2 traités par de l’insuline

V. Pechtner, C. Cueille, S. Choi, D. Shrom, L. Ilag

Journal:

Diabetes & Metabolism

Year:

2009

Language:

french

File:

PDF, 76 KB

french, 2009

13

Role of urothelial surface mucoprotein in intrinsic bladder defense

Stanley H. Shrom, C. Lowell Parsons, S. Grant Mulholland

Journal:

Year:

1977

Language:

english

File:

PDF, 5.99 MB

english, 1977

14

Clinical profile of experience with 130 consecutive cases of impotent men

Stanley H. Shrom, Harold I. Lief, Alan J. Wein

Journal:

Year:

1979

Language:

english

File:

PDF, 648 KB

english, 1979

15

Megalourethra

Stanley H. Shrom, William J. Cromie, John W. Duckett Jr.

Journal:

Year:

1981

Language:

english

File:

PDF, 361 KB

english, 1981

16

Augmentation ileocystoplasty in neuropathic bladder

David M. Raezer, Robert J. Evans, Stanley H. Shrom

Journal:

Year:

1985

Language:

english

File:

PDF, 592 KB

english, 1985

17

Surgical treatment of reflux in neurologically impaired child

Robert J. Evans, David M. Raezer, Stanley H. Shrom

Journal:

Year:

1986

Language:

english

File:

PDF, 586 KB

english, 1986

18

How Various Plasma Glucose (PG) Measures Correlate with A1C in Insulin-treated Type 2 Diabetes (T2D)

Chan, John, Ilag, Liza L., Sarwat, Samiha, Heine, Robert J., Shrom, David S.

Journal:

Canadian Journal of Diabetes

Year:

2008

Language:

english

File:

PDF, 572 KB

english, 2008

19

IL-17 Induces Inflammation-Associated Gene Products in Blood Monocytes, and Treatment with Ixekizumab Reduces Their Expression in Psoriasis Patient Blood

Wang, Claire Q F, Suárez-Fariñas, Mayte, Nograles, Kristine E, Mimoso, Claudia A, Shrom, David, Dow, Ernst R, Heffernan, Michael P, Hoffman, Robert W, Krueger, James G

Journal:

The Journal of Investigative Dermatology

Year:

2014

Language:

english

File:

PDF, 1.02 MB

english, 2014

20

Early clinical response as a predictor of subsequent response to ixekizumab treatment: results from a phase II study of patients with moderate-to-severe plaque psoriasis

Zhu, B., Edson-Heredia, E., Cameron, G.S., Shen, W., Erickson, J., Shrom, D., Wang, P., Banerjee, S., Gordon, K.B.

Journal:

British Journal of Dermatology

Year:

2013

Language:

english

File:

PDF, 245 KB

english, 2013

21

Forebrain degeneration and ventricle enlargement caused by double knockout of Alzheimer's presenilin-1 and presenilin-2

Feng, R., Wang, H., Wang, J., Shrom, D., Zeng, X., Tsien, J. Z.

Journal:

Proceedings of the National Academy of Sciences

Year:

2004

Language:

english

File:

PDF, 709 KB

english, 2004

22

Ixekizumab dans le traitement du psoriasis en plaques modéré à sévère : résultats à 60 semaines d’une étude de phase 3, en double aveugle, avec une phase d’induction suivie d’une phase de re-randomisation (UNCOVER-1)

Gordon, K., Blauvelt, A., Langley, R., Luger, T., Ohtsuki, M., Cameron, G., Braun, D., Erickson, J., Zhao, F., Shrom, D., Osuntokun, O., Heffernan, M., Nickoloff, B., Leonardi, C., Augendre-Ferrante,

Journal:

Annales de Dermatologie et de Vénéréologie

Year:

2015

Language:

french

File:

PDF, 75 KB

french, 2015

23

Canada – Guyana medical education project: a Win-Win partnership among trainees?

Weaver, V.K., Stokes, W.B., Manji, F., Shrom, Y.

Journal:

Annals of Global Health

Year:

2016

Language:

english

File:

PDF, 42 KB

english, 2016

24

056 Impact of ixekizumab on palmoplantar plaque psoriasis compared to placebo and etanercept: results from UNCOVER 2

Menter, A., Reich, K., Warren, R.B., Duffin, K.C., Langley, R., Kerr, L., Dennehy, E., Shrom, D.S., Amato, D.

Journal:

The Journal of Investigative Dermatology

Year:

2016

Language:

english

File:

PDF, 59 KB

english, 2016

25

Rapidité d’action de l’ixékizumab : analyse groupée de 2 essais randomisés de phase 3 (UNCOVER-2 et 3) chez des patients atteints de psoriasis

Leonardi, C., Langley, R., Blauvelt, A., Gordon, K., Shrom, D.-S., Farmer Kerr, L.-N., Stoykov, I., Ojeh, C., Reich, K., Augendre-Ferrante, B.

Journal:

Annales de Dermatologie et de Vénéréologie

Year:

2016

Language:

french

File:

PDF, 51 KB

french, 2016

26

Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis

Blauvelt, A., Papp, K.A., Sofen, H., Augustin, M., Yosipovitch, G., Katoh, N., Mrowietz, U., Ohtsuki, M., Poulin, Y., Shrom, D., Burge, R., See, K., Mallbris, L., Gordon, K.B.

Journal:

Journal of the European Academy of Dermatology and Venereology

Year:

2017

Language:

english

File:

PDF, 797 KB

english, 2017

27

Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experience

Callis Duffin, Kristina, Bukhalo, Michael, Bobonich, Margaret, Shrom, David, Zhao, Fangyi, Kershner, James, Gill, Anne, Pangallo, Beth, Shuler, Catherine, Bagel, Jerry

Journal:

Medical Devices Evidence and Research

Year:

2016

Language:

english

File:

PDF, 510 KB

english, 2016

28

Patient Perspective on the Burden of Skin and Joint Symptoms of Psoriatic Arthritis: Results of a Multi-National Patient Survey

Merola, Joseph F., Shrom, David, Eaton, Jennifer, Dworkin, Christine, Krebsbach, Craig, Shah-Manek, Bijal, Birt, Julie

Journal:

Rheumatology and Therapy

Year:

2019

Language:

english

File:

PDF, 1.06 MB

english, 2019

29

Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis

Gladman, Dafna D., Orbai, Ana-Maria, Klitz, Uta, Wei, James Cheng-Chung, Gallo, Gaia, Birt, Julie, Rathmann, Suchitrita, Shrom, David, Marzo-Ortega, Helena

Journal:

Arthritis Research & Therapy

Year:

2019

Language:

english

File:

PDF, 644 KB

english, 2019

30

The Relationship between Self-Monitored Blood Glucose Values and Glycated haemoglobin in Insulin-treated Patients with Type 2 Diabetes

Sarwat, S., Ilag, L. L., Carey, M. A., Shrom, D. S., Heine, R. J.

Journal:

Diabetic Medicine

Year:

2009

Language:

english

File:

PDF, 104 KB

english, 2009

31

540 Rapid response in PASI, sPGA, and BSA measures for patients with moderate-to-severe plaque psoriasis with ixekizumab

Leonardi, C., Burge, R., See, K., Shrom, D., Guo, J., McKean-Matthews, M., Amato, D., Gallo, G., Gooderham, M.

Journal:

The Journal of Investigative Dermatology

Year:

2019

Language:

english

File:

PDF, 199 KB

english, 2019

32

713 The association between disease severity at time of retreatment and probability of recapture in psoriasis patients receiving ixekizumab

Leonardi, C., Mroweitz, U., See, K., Shrom, D., McKean-Matthews, M., Gallo, G., Nickoloff, B.J., Wu, J.

Journal:

The Journal of Investigative Dermatology

Year:

2019

Language:

english

File:

PDF, 201 KB

english, 2019

33

567 Stability of PASI 90 response in psoriasis patients treated with ixekizumab or ustekinumab

Gottlieb, A., Rosmarin, D., Muram, T., Lin, C., Shrom, D.S.

Journal:

The Journal of Investigative Dermatology

Year:

2019

Language:

english

File:

PDF, 193 KB

english, 2019

34

Increased rates of vesicoureteral reflux in mice from deletion of Dicer in the peri-Wolffian duct stroma

Anslow, Melissa J., Bodnar, Andrew J., Cerqueira, DÃ©bora M., Bushnell, Daniel, Shrom, Brynn E., Sims-Lucas, Sunder, Bates, Carlton M., Ho, Jacqueline

Journal:

Pediatric Research

Year:

2020

Language:

english

File:

PDF, 4.24 MB

english, 2020

35

14160 Treatment satisfaction in patients with moderate to severe psoriasis by drug class and dose frequency: Results from a United States web-based survey

Armstrong, April W., Shrom, David, Burge, Russel, Zhu, Baojin, Gorelick, Joe

Journal:

Journal of the American Academy of Dermatology

Year:

2020

File:

PDF, 8.20 MB

2020

36

13876 Achieving a PASI 50 at 2 weeks was associated with better long-term clinical outcomes and low discontinuation: A subgroup analysis of a phase 3 trial of ixekizumab and etanercept in moderate to severe psoriasis

Rosmarin, David, Shrom, David, Burge, Russel, See, Kyoungah, McKean-Matthews, Missy, Ridenour, Terri

Journal:

Journal of the American Academy of Dermatology

Year:

2020

File:

PDF, 243 KB

2020

37

13877 Treatment goals of patients with psoriasis as assessed by the Patient Benefit Index: Results of a National Psoriasis Foundation survey

Armstrong, April, Edson-Heredia, Emily, Zhu, Baojin, Shrom, David, Burge, Russel, Bell, Stacie, Crowley, Jeffrey J., Smith, Stacy

Journal:

Journal of the American Academy of Dermatology

Year:

2020

File:

PDF, 789 KB

2020

38

16007 Ixekizumab demonstrated longer medication persistence than other biologics in the treatment of psoriasis patients: Results from IBM MarketScan databases

Blauvelt, Andrew, Leonardi, Craig L., Lebwohl, Mark, Zhu, Baojin, Malatestinic, William, Eastman, Joe Eastman, Guo, Jiaying, Shrom, David, Murage, Mwangi J., Burge, Russel

Journal:

Journal of the American Academy of Dermatology

Year:

2020

File:

PDF, 272 KB

2020

39

15984 Psoriasis patients treated with ixekizumab were maintained longer on monotherapy compared with other biologics in real-world clinical practice settings: Results from IBM MarketScan databases

Leonardi, Craig L., Blauvelt, Andrew, Zhu, Baojin, PharmD, WIlliam Malatestinic, Joe Eastman, William, Guo, Jiaying, Shrom, David, Burge, Russel, Lebwohl, Mark

Journal:

Journal of the American Academy of Dermatology

Year:

2020

File:

PDF, 96 KB

2020

40

14162 Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis

Blauvelt, Andrew, Burge, Russel, Zhu, Baojin, Shrom, David, Guo, Jiaying, Malatestinic, WIlliam

Journal:

Journal of the American Academy of Dermatology

Year:

2020

File:

PDF, 812 KB

2020